| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780653 | Gynecologic Oncology | 2018 | 7 Pages |
Abstract
In the short-term, NACT is a cost-effective alternative compared to PCS in women with AEOC. These results may translate to longer term cost-effectiveness; however, data from randomized control trials continues to mature.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Arthur-Quan Tran, Daniel O. Erim, Stephanie A. Sullivan, Ashley L. Cole, Emma L. Barber, Kenneth H. Kim, Paola A. Gehrig, Stephanie B. Wheeler,